secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001404644-24-000080
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurogene posts updated corporate presentation; details not provided in filing excerpt
--------------------------------------------------------------------------------

- Updated corporate presentation posted on company website on June 21, 2024.
- Presentation is furnished as an exhibit to this 8-K, but its full content is not included in the provided text.
- No specific numbers, pipeline updates, or financial figures are available from the excerpt.
- Investors should refer to the full presentation on Neurogene's website for material updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000140464424000080/0001404644-24-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000140464424000080/ngne-20240621.htm
  HTML page:      https://secwatch.observer/filing/0001404644-24-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer